Jim Jingjun Huang
Ascendia Pharmaceuticals, USA
Biography
Jim Jingjun Huang received his PhD in Pharmaceutics from the University of the Sciences in Philadelphia under Joseph B. Schwartz. He has more than 15 years of experience in preclinical and clinical formulation development and commercialization of a variety of oral and parenteral dosage forms during his tenure at Ascendia, Roche, AstraZeneca, Baxter and Wyeth. He is currently CEO/CSO of Ascendia Pharmaceuticals. His publications include studies on solubilization and drug delivery technologies of poorly water soluble drug. He has served as expert reviewer for several peer-review international journals. He is a member of American Association of Pharmaceutical Scientists (AAPS) and American Chemical Society (ACS).\r\n
Abstract
Abstract : Rational design of amorphous solid dispersion for solubility and bioavailability enhancement
